PDCD1 and neoplasm: To address this dilemma, PD-1/PD-L1 expression levels using IHC staining served as a commonly used evaluation metric; however, its predictive value for PD-1/PD-L1 is tumor type-dependent, and PD-1/PD-L1 negative patients also responded to immunotherapy [45].